Hims & Hers Health
HIMS
134 hedge funds and large institutions have $527M invested in Hims & Hers Health in 2022 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 42 increasing their positions, 33 reducing their positions, and 27 closing their positions.
138% more call options, than puts
Call options by funds: $6.97M | Put options by funds: $2.93M
27% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 33
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
4% more ownership
Funds ownership: 46.26% → 50.26% (+4%)
5% less funds holding
Funds holding: 141 → 134 (-7)
11% less capital invested
Capital invested by funds: $592M → $527M (-$65.6M)
26% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$8.06M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$5.2M |
| 3 |
FCMV
Foresite Capital Management V
Larkspur,
California
|
+$4.95M |
| 4 |
Renaissance Technologies
New York
|
+$3.09M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTA
Disruptive Technology Advisers
Austin,
Texas
|
-$16.7M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$12.7M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$9.92M |
| 4 |
Two Sigma Investments
New York
|
-$2.56M |
| 5 |
OCM
Oaktree Capital Management
Los Angeles,
California
|
-$2.48M |
HIMS Hedge Fund Activity: Q1 2022 in Review
134 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Hims & Hers Health (HIMS) for Q1 2022, worth a combined $527M — down 11% from $592M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of HIMS and 20 opened new positions — a net loss of 7 holders — while 33 trimmed existing stakes and 42 added.
The largest buyer was Millennium Management, adding an estimated $8.06M. The largest seller was Disruptive Technology Advisers, exiting entirely with an estimated $16.7M sold.
- 134 institutional investors held Hims & Hers Health (HIMS) as of Q1 2022, down from 141 in Q4 2021.
- Funds reported $527M of Hims & Hers Health stock for Q1 2022, down 11% quarter-over-quarter.
- 20 funds opened new Hims & Hers Health positions in Q1 2022 and 27 closed out, a net change of -7 holders.
- The largest Hims & Hers Health buyer in Q1 2022 was Millennium Management, an estimated $8.06M added.
- The largest Hims & Hers Health seller in Q1 2022 was Disruptive Technology Advisers, an estimated $16.7M sold.
Based on aggregated 13F filings for Q1 2022.